BioInvent International Balance Sheet Health
Financial Health criteria checks 6/6
BioInvent International has a total shareholder equity of SEK1.5B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK1.6B and SEK89.4M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 978.04m |
| Equity | SEK 1.47b |
| Total liabilities | SEK 89.37m |
| Total assets | SEK 1.56b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BOVN.F's short term assets (SEK1.3B) exceed its short term liabilities (SEK70.8M).
Long Term Liabilities: BOVN.F's short term assets (SEK1.3B) exceed its long term liabilities (SEK18.6M).
Debt to Equity History and Analysis
Debt Level: BOVN.F is debt free.
Reducing Debt: BOVN.F has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BOVN.F has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: BOVN.F has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 18.4% each year.